← Home / TRAVERE THERAPEUTICS, INC. (TVTX)
Stock Analysis
TRAVERE THERAPEUTICS, INC. (TVTX)
TVTX
TVTX · Market data
55.99 -4.25%
52W Range Position
93%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-10 16:15 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 59.03. Holding above 49.74 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
49.74
↗
Break Above
Confirmation improves above resistance.
59.03
🎯
Next Objective
Pattern-derived target if setup continues.
69.59
×
Thesis Break
Scenario weakens below invalidation.
Below 49.74
What's Driving TVTX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 59.03 for confirmation and 49.74 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 49.74
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Bull Flag · Confirmed
Trigger
58.34
Target
69.59
Invalidation
54.87
Bull Flag
Q 0.73 / age 3
Flag Target
69.16
Price Chart
TVTX · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-09
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$5.4B
Company size
EV
$5.4B
Debt-adjusted value
P/S
10.1
Premium
P/B
54.7
Very high
EV/Sales
10.0
Premium
P/FCF
139.1
Very high
FCF Yield
0.72%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Pressured
💵 Revenue
127.20M
↗ Strong
📈 Net Income
-37.10M
↘ Negative
🧮 EPS (Basic)
-0.40
↘ Negative
TRAVERE THERAPEUTICS, INC.
Related Opportunities